| Phospholipid vesicles for dermal/transdermal and nasal administration of active molecules: The effect of surfactants and alcohols on the fluidity of their lipid bilayers and … H Natsheh, E Touitou Molecules 25 (13), 2959, 2020 | 97 | 2020 |
| Ethosomes for dermal administration of natural active molecules H Natsheh, E Vettorato, E Touitou Current pharmaceutical design 25 (21), 2338-2348, 2019 | 48 | 2019 |
| Topical administration of drugs incorporated in carriers containing phospholipid soft vesicles for the treatment of skin medical conditions E Touitou, H Natsheh Pharmaceutics 13 (12), 2129, 2021 | 26 | 2021 |
| Phospholipid Magnesome—a nasal vesicular carrier for delivery of drugs to brain H Natsheh, E Touitou Drug delivery and translational research 8, 806-819, 2018 | 23 | 2018 |
| A new nanovesicular system for nasal drug administration E Touitou, S Duchi, H Natsheh International Journal of Pharmaceutics 580, 119243, 2020 | 21 | 2020 |
| Enhanced therapeutic anti-inflammatory effect of betamethasone on topical administration with low-frequency, low-intensity (20 kHz, 100 mW/cm2) ultrasound exposure on … G Cohen, H Natsheh, Y Sunny, CR Bawiec, E Touitou, MA Lerman, ... Ultrasound in medicine & biology 41 (9), 2449-2457, 2015 | 14 | 2015 |
| Buspirone nanovesicular nasal system for non-hormonal hot flushes treatment E Touitou, H Natsheh, S Duchi Pharmaceutics 10 (3), 82, 2018 | 11 | 2018 |
| Short onset and enhanced analgesia following nasal administration of non-controlled drugs in nanovesicular systems E Touitou, H Natsheh, S Boukeileh, R Awad Pharmaceutics 13 (7), 978, 2021 | 9 | 2021 |
| Characterization and Investigation of Novel Benzodioxol Derivatives as Antidiabetic Agents: An In Vitro and In Vivo Study in an Animal Model M Hawash, D Al-Smadi, A Kumar, B Olech, PM Dominiak, N Jaradat, ... Biomolecules 13 (10), 1486, 2023 | 8 | 2023 |
| Improved efficiency of pomegranate seed oil administrated nasally H Natsheh, E Touitou Pharmaceutics 14 (5), 918, 2022 | 7 | 2022 |
| inventors; Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., assignee E Touitou, H Natsheh Cannabinoids compositions and methods patent WO2019106652, 2019 | 6 | 2019 |
| Compositions and methods for nasal administration of drugs to brain and for systemic effect E Touitou, H Natsheh US Patent 11,389,404, 2022 | 4 | 2022 |
| Evaluating the Neuroprotective Potential of Novel Benzodioxole Derivatives in Parkinson’s Disease via AMPA Receptor Modulation M Hawash, M Qneibi, H Natsheh, NH Mohammed, LA Hamda, A Kumar, ... ACS Chemical Neuroscience, 2024 | 3 | 2024 |
| The evolution of emerging nanovesicle technologies for enhanced delivery of molecules into and across the skin E Touitou, H Natsheh Pharmaceutics 16 (2), 267, 2024 | 3 | 2024 |
| Capsicum annuum Oleoresin Nanoemulgel-Design Characterization and In vitro Investigation of Anticancer and Antimicrobial Activities AM Eid, H Natsheh, L Issa, M Zoabi, M Amer, E Mahamid, A Mousa Current Pharmaceutical Design 30 (2), 151-160, 2024 | 2 | 2024 |
| Film Forming Systems for Delivery of Active Molecules into and across the Skin E Touitou, H Natsheh, J Zailer Pharmaceutics 15 (2), 397, 2023 | 2 | 2023 |
| Modified Release 3D-Printed Capsules Containing a Ketoprofen Self-Nanoemulsifying System for Personalized Medical Application B Shaqour, H Natsheh, N Kittana, N Jaradat, M Abualhasan, AM Eid, ... ACS Biomaterials Science & Engineering, 2024 | 1 | 2024 |
| Orally administrable cannabinoids-containing compositions and methods E Touitou, H Natsheh US Patent App. 17/289,932, 2022 | 1 | 2022 |
| Compositions and methods for nasal administration of drugs to brain and for systemic effect E Touitou, H Natsheh US Patent 12,064,508, 2024 | | 2024 |
| Evaluation of nasal delivery systems of olanzapine by desorption electrospray ionization mass spectrometry imaging L Messer, A Zoabi, R Yakobi, H Natsheh, E Touitou, K Margulis International Journal of Pharmaceutics 650, 123664, 2024 | | 2024 |
